معرفی
Kumari Kanchan is a Postdoctoral Fellow at the Department of Molecular Biology, Umeå University, Sweden, working in the research group of Francesca Aguilo. Her office is located at the Hospital area (6K and 6L), Umeå.
Her research focuses on epigenetics, stem cell biology, and cancer mechanisms. Key areas include the role of LSD1 in DNA methylation and stem cell differentiation, RNA modifications in breast cancer, and the development of DNA nanostructures for targeted cancer therapy. She also investigates biophysical interactions of drugs like artemisinin and the interplay between thyroid disorders and infectious diseases.
Analysis of her recent publications (2020-2024) reveals a strong emphasis on epigenetic regulation in stem cells and cancer. Her work on LSD1 and CHD7 has uncovered critical mechanisms in mouse embryonic stem cell differentiation and chromatin dynamics. Additionally, she has pioneered the use of DNA nanostructures for miRNA delivery in cancer models and explored RNA epitranscriptomics in breast cancer pathogenesis.
Scientific Awards: No awards were mentioned in the provided information.
Advising and Grants: No details on student advising or research grants were available in the source material.
Laboratory and Team: Dr. Kumari is an active member of the Francesca Aguilo research group at Umeå University's Department of Molecular Biology, contributing to projects on epigenetics and stem cell biology within the hospital campus environment.
